Research programme: schizophrenia therapies - deCODE genetics

Drug Profile

Research programme: schizophrenia therapies - deCODE genetics

Latest Information Update: 30 Jan 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator deCODE genetics
  • Class Small molecules
  • Mechanism of Action ERBB 4 receptor agonists; NMDA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Schizophrenia

Most Recent Events

  • 26 Jul 2007 Preclinical development is ongoing
  • 23 Aug 2005 This programme is still in active development
  • 16 Dec 2002 Preclinical data from a media release have been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top